Soligenix, Inc. Common Stock
SNGX Real Time Price USDRecent trades of SNGX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by SNGX's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Compositions and methods of manufacturing trivalent filovirus vaccines Oct. 03, 2023
-
Patent Title: Compositions and methods of manufacturing trivalent filovirus vaccines Sep. 06, 2022
-
Patent Title: Peptides and analogs for use in the treatment of oral mucositis Apr. 26, 2022
-
Patent Title: Systems and methods for producing synthetic hypericin Jan. 07, 2020
-
Patent Title: Multivalent stable vaccine composition and methods of making same May. 21, 2019
-
Patent Title: Peptides and analogs for use in the treatment of oral mucositis Apr. 09, 2019
-
Patent Title: Systems and methods for producing synthetic hypericin Aug. 21, 2018
-
Patent Title: Peptides and analogs for use in the treatment of oral mucositis Dec. 26, 2017
-
Patent Title: Topically active steroids for use in interstitial pulmonary fibrosis Sep. 19, 2017
-
Patent Title: Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity Aug. 16, 2016
-
Patent Title: Topically active steroids for use in interstitial pulmonary fibrosis Oct. 27, 2015
-
Patent Title: Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity Jul. 29, 2014
-
Patent Title: Stabilized reverse micelle compositions and uses thereof Sep. 17, 2013
-
Patent Title: Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids Sep. 11, 2012
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of SNGX in WallStreetBets Daily Discussion
Recent insights relating to SNGX
Recent picks made for SNGX stock on CNBC
ETFs with the largest estimated holdings in SNGX
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SNGX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.